XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
  Breast
  Skin
  Blood
  Prostate
  Liver
  Colon
  Thyroid
  Endometrial
  Brain
  Therapy
  Risk Factors
  Esophageal
  Bladder
  Lung
  Rectal Cancer
  Pancreatic Cancer
  Bone Cancer
  Cervical Cancer
  Testicular Cancer
  Gastric Cancer
  Ovarian Cancer
  Nerve Tissue
  Renal Cell Carcinoma
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Aug 19th, 2006 - 22:18:38

Breast Channel
subscribe to Breast newsletter

Latest Research : Cancer : Breast

   DISCUSS   |   EMAIL   |   PRINT
Mammaglobin Blood Test Reliably Detects Breast Cancer Recurrence
Nov 11, 2005, 00:22, Reviewed by: Dr.

Mammaglobin was discovered in Fleming's laboratory in the late 1990s through the efforts of Fleming and then-postdoctoral associate Mark A. Watson, M.D., Ph.D.

 
Researchers at Washington University School of Medicine in St. Louis have shown that mammaglobin, a protein secreted by breast tumor cells, can readily be detected in the blood serum of patients with metastatic breast cancer using an inexpensive, reliable clinical test.

"A test for mammaglobin holds significant promise for catching metastatic tumors early," says study co-author Timothy P. Fleming, Ph.D., research associate professor of surgery at the School of Medicine and a researcher with the Siteman Cancer Center. "Compared to the few other known biomarkers linked to breast cancer, mammaglobin is the best. The protein is found in breast tissue and is secreted by most breast tumors."

The study, published in Clinical Cancer Research, tested 56 women without breast cancer and 26 women with metastatic breast cancer. The women without breast cancer were found to have a steady, low level of mammaglobin in their blood. This baseline level was not affected by age, body mass index, menopausal status, race, smoking history or a family history of breast cancer.

In contrast, the women with metastatic breast cancer had on average much higher readings of mammaglobin than the baseline level, providing the potential to distinguish cancer-free patients from those with recurrent breast tumors.

In addition, about 80 percent of all breast cancers examined, regardless of the type of tumor or stage of development, tested strongly for mammaglobin while normal breast tissue had significantly less mammaglobin. Prostate, colon, lung and ovarian cancer tissues did not test positive for mammaglobin.

This study shows that mammaglobin levels in blood serum can be readily obtained with a test called ELISA, an inexpensive clinical test often used to measure protein levels in fluids.

The test detected even very low concentrations of mammaglobin in blood serum and maintained accuracy over a 1,000-fold increase of mammaglobin concentration. Serum samples subjected to repeated freezing and thawing or stored frozen for a year tested just as effectively as fresh samples, indicating no potential problems with sample storage.

"Originally, we identified the gene that produces mammaglobin because it is activated in breast cancer relative to non-malignant breast cells," says study co-author Watson, associate professor of pathology and immunology and director of the Multiplexed Gene Analysis Core and Tissue Procurement Core at Siteman. "It's exciting to be a part of the research developments surrounding mammaglobin," Fleming says. Next, we are planning to work on high-throughput techniques to test our mammaglobin blood test in a much larger study."
 

- Bernstein JL, Godbold JH, Raptis G, Watson MA, Levinson B, Aaronson SA, Fleming TP. Identification of mammaglobin as a novel serum marker for breast cancer. Clinical Cancer Research, 2005;11(18):6528-6535.
 

medschool.wustl.edu

 
Subscribe to Breast Newsletter
E-mail Address:

 

Funding from the Breast Cancer Research Foundation, the National Cancer Institute and the National Institutes of Health supported this research.

Washington University School of Medicine's full-time and volunteer faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Children's hospitals. The School of Medicine is one of the leading medical research, teaching and patient care institutions in the nation, currently ranked third in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Children's hospitals, the School of Medicine is linked to BJC HealthCare.

Siteman Cancer Center is the only NCI-designated Comprehensive Cancer Center within a 240-mile radius of St. Louis. Siteman Cancer Center is composed of the combined cancer research and treatment programs of Barnes-Jewish Hospital and Washington University School of Medicine.


Related Breast News

Breast cancer chemotherapy may deterioration in cognitive function
Elderly Breast Cancer Patients May Be Under-Diagnosed And Under-Treated
Tissue Geometry Plays Crucial Role in Breast Cell Invasion
Ethnic variations in hormone levels may cause differences in breast cancer risk
Researchers set benchmarks for screening mammography
Raloxifene Reduces Breast Cancer Risk in Postmenopausal Women at All Risk Levels
Physical activity improves survival in breast cancer patients
Pedigree assessment tool correctly identifies women with higher risk of breast cancer
MRI more accurately determines cancer spread into breast ducts
Core needle biopsy gives an accurate picture of gene expression


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us